Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study
Fengzhu Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jin‐Hu Fan(Chinese Academy of Medical Sciences & Peking Union Medical College), You‐Lin Qiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayu Wang(Nanjing University of Chinese Medicine), Pei Yu(Shanghai Jiao Tong University), Su Zhang(Fujian Medical University), Huawei Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Min Yan(Zhengzhou University), Li Cai(Wenzhou Medical University), Xinlan Liu(Yunnan Agricultural University), Tao Sun(Liaoning Cancer Hospital & Institute), Xichun Hu(Fudan University Shanghai Cancer Center), Tao Huang(Union Hospital), Yuee Teng(First Hospital of China Medical University), Zhongsheng Tong(Institute of Oncology NN Petrov), Yang Shun-e(Xinjiang Medical University), Xi Chen(Zhejiang Cancer Hospital), Hui Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Shusen Wang(Sun Yat-sen University), Xiaojia Wang(Wenzhou Medical University), Yongmei Yin(Jiangsu Cancer Hospital), Hongyuan Li(Central South University), Runxiang Yang(Kunming Medical University), Quchang Ouyang(Hunan Cancer Hospital), Jianjun He(Hebei Medical University), Yiqun Han(Mayo Clinic), Wenna Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zongbi Yi(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 9
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
|International Journal of Cancer|2006|417